Noviembre-Enero 2000 N°2
DOI:10.70024 / ISSN 1317-987X
 
Buscar




Artículos
 



Infectología
Infección post-quirúrgica por Microbacterias atípicas de crecimiento rápido. Una complicación inesperada de Liposucción y Lipoescultura

Referencias

Referencias

  1. Irausquin de Postalian E, Marcano de Cuenca R, Serra L, Fileni N. Infección por Mycobacterium fortuitum: a propósito de dos casos post ritidectomía y blefaroplastia. Gac Med Caracas 1994; 102: 170-172.
  2. Safranek TJ, Jarvis WR, Carson LA, Cusick LB, Bland LA, Swenson JM, and Silcox VA. Mycobacterium chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med 1987;317: 197-201.
  3. Waine S, Larrabe W, Broke D. Rhytidectomy techniques and complications. Am J Otolaryngol 1992;13: 1-15.
  4. Toranto IR, Mallow JB. Atypical Mycobacteria periprosthetic infections, diagnosis and treatment. Plast Reconstr Surg 1980; 66: 226-228.
  5. Clegg HW, Foster MT, Sanders WE Jr, Baine WB. Infection due to organisms of the Mycobacterium fortuitum complex after augmentation mammaplasty : clinical and epidemiological features. J Infect Dis 1983; 147: 427-433.
  6. Clegg HW, Bertagnoll P, Hightower AW, Baine WB. Mammaplasty associated mycobacterial infection : a survey of plastic surgeons. Plast Reconstr Surg 1983; 72: 165-169.
  7. Continued experience with mycobacteria. Bull Int Soc Clin Plast Surg 1985; 9: 6.
  8. Mc Farland E, Kuritzkes D. Clinical features and treatment of infection due to Mycobacterium fortuitum-chelonae complex. In: Remington J, Swartz M, editors .Current Clinical Topics in Infectious Diseases .Vol 13.Boston: Blackwell Scientific Publications;1993.p. 188-202.
  9. Nolte FS, Metchock B. Mycobacterium. In Murray PR, Chief editor, Baron EJ. Pfaller MA., Tenover FC., Yolken RH., editors. Manual of Clinical Microbiology. ASM press; 1996. p. 400-432.
  10. Wallace R Jr. The clinical presentation, diagnosis and therapy of cutaneous and pulmonary infections due to rapidly growing mycobacteria, M.fortuitum and M.chelonae. Clin Chest Med 1989; 10: 419-429.
  11. Wallace R Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983; 5: 657-679.
  12. Burns DN, Rohatgi PK, Rosenthal R, Seiler M, and Gordin FM. Disseminated Mycobacterium fortuitum successfully treated with combination therapy including ciprofloxacin. Am Rev Respir Dis 1990; 142: 468-470.
  13. Fonseca E, Alzate C, Canedo T, Contreras F. Nodular lesions in disseminated Mycobacterium fortuitum infection. Arch Dermatol 1987; 123: 1603-1604.
  14. Nelson BR, Rapini RP, Wallace RJ, Tschen JA. Disseminated Mycobacterium chelonae ssp. abscessus in an immunocompetent host with a known portal of entry. J Am Acad Derm 1989;20: 909-912.
  15. Hoffman PC, Fraser DW, Robiscek F, O?Bar PR, Mauney CV. Two outbreaks of sternal wound infections due to organisms of the Mycobacterium fortuitum complex. J Infect Dis 1981;143: 533-542.
  16. Kuritsky JN, Bullen MG, Brome CV, Silcox BA, Good RC, Wallace RJ. Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med 1983;98:938-939.
  17. Torres JR, Rios-Fabra A, Murillo J, Montecinos E, Caceres AM. Injection site abscess due to the Mycobacterium fortuitum-chelonae complex in the immunocompetent host. Infect Dis Clin Pract 1998;7:56-60.
  18. Villanueva A, Villanueva Calderón R, Acosta Vargas B, Ruíz F, Aguero S, Zhang Y, and Wallace Jr R. Report of an outbrake of post injection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison with strains by random amplified polymorphic DNA polymerase. Clin Infect Dis 1.997; 24:1147-1153.
  19. Center for Disease Control and Prevention. Infection with Mycobacterium abscessus associated with intramuscular injection of adrenal cortex extract-Colorado and Wyoming. 1995-1996. MMWR Morb Mortal Wkly rep 1996;45:713-715.
  20. Wallace R Jr, Brown BA and Onyi GO. Skin, soft tissue and bone infections due to Mycobacterium chelonae : importance of prior corticosteroid therapy , frequency of disseminated infections, and resistance to oral antimicrobials other than Clarithromycin .J Infect Dis 1992;166: 405-412.
  21. Subbarao KE, Tarpay MM, Marks MI. Soft tissue infections caused by Mycobacterium fortuitum complex following penetrating injury. Am J Dis Child 1987;141: 1018-1020.
  22. Repath F, Seabury JH, Sanders CV and Domer J. Prosthetic valve endocarditis due to Mycobacterium chelonei. South Med J 1976; 69:1244-1246.
  23. Wallace R Jr. Recent changes in taxonomy and disease manifestations of the rapidly growing mycobacteria. Eur J Clin Microbiol Infect Dis 1994;13: 953-960.
  24. Soto LE, Bobadilla M, Villalobos Y, Sifuentes J, Avelar J, Arrieta M, Ponce de Leon S. Post-surgical nasal cellulitis outbreak due to Mycobacterium chelonae. J Hosp Infect 1991;19: 99-106.
  25. Carson LA, Peterson NJ, Favero MS, Aguero SM. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Envirom Microbiol 1978; 36: 839.
  26. Pope J Jr, Sternberg P, McLane NJ, Potts DW, Stulting RD. Mycobacterium chelonae scleral abscesses after removal of scleral buckle. Am J Ophthalmol 1989;107: 557-558.
  27. Lowry PW, Jarvis WR, Oberle AD, Bland LA, Silverman R, Bocchini JA, Dean HD, Swenson JM, Wallace RD. Mycobacterium chelonae causing otitis media in an ear-nose-and throat practice. N Engl J Med 1988; 319:978-982.
  28. Rutala WA, Shafer K. Cleaning, Disinfection and Sterilization. In: Olmsted RJ, editor. APIC Infection control and applied epidemiology. Principles and Practice. Mosby-year Book,Inc.1996.p.15-1_15-17.
  29. Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of non pulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 1985;152: 500-514.
  30. Penne Kamp et al. Ann Plastic surgery 1997;39:80-83.
  31. Tsukamura M, Nakamura E, Kurita I, Nakamura T. Isolation of Mycobacterium chelonei subspecies chelonei (Mycobacterium bostelense) from pulmonary lesions of 9 patients. Am Rev Resp Dis 1973;108:683-685.
  32. Gruft H, Henning HG. Pulmonary mycobacteriosis due to rapidly growing acid fast bacillus, Mycobacterium chelonae. Am Rev Resp Dis 1972;105:618-620.
  33. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ III. Activities of four macrolides, including Clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180-184.
  34. Wallace RJ Jr., Tanner D, Brennan P, Brown B. Clinical trial of Clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 1993;119:482-486.
  35. Swenson JM, Thornsberry C, Silcox VA. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother 1982;22:186-192.
  36. Wallace RJ Jr, Hull SI, Bobey DG, et al. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonae. Am Rev Resp Dis 1985:132:409-416.
Introducción
Materiales y métodos
Resultados
Discusión
Referencias

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit